BSE Live
Oct 03, 16:01Prev. Close
1636.15
Open Price
1605.95
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 03, 15:59Prev. Close
1636.20
Open Price
1600.00
Bid Price (Qty.)
1631.20 (41)
Offer Price (Qty.)
0.00 (0)
Balance Sheet of Sun Pharmaceutical Industries (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
EQUITIES AND LIABILITIES | ||||||
SHAREHOLDER'S FUNDS | ||||||
Equity Share Capital | 239.93 | 239.93 | 239.93 | 239.93 | 239.93 | |
Total Share Capital | 239.93 | 239.93 | 239.93 | 239.93 | 239.93 | |
Reserves and Surplus | 24,099.92 | 23,454.47 | 23,508.43 | 24,348.02 | 24,800.23 | |
Total Reserves and Surplus | 24,099.92 | 23,454.47 | 23,508.43 | 24,348.02 | 24,800.23 | |
Total Shareholders Funds | 24,339.85 | 23,694.40 | 23,748.36 | 24,587.95 | 25,040.16 | |
NON-CURRENT LIABILITIES | ||||||
Long Term Borrowings | 0.00 | 11,036.01 | 7,586.73 | 4,865.64 | 4,833.56 | |
Deferred Tax Liabilities [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Other Long Term Liabilities | 543.59 | 1,669.51 | 1,080.18 | 808.43 | 160.72 | |
Long Term Provisions | 241.48 | 219.73 | 206.16 | 397.63 | 620.84 | |
Total Non-Current Liabilities | 785.07 | 12,925.25 | 8,873.07 | 6,071.70 | 5,615.12 | |
CURRENT LIABILITIES | ||||||
Short Term Borrowings | 10,954.47 | 10.60 | 5.94 | 3.07 | 1,651.98 | |
Trade Payables | 3,433.94 | 2,619.58 | 3,125.58 | 2,710.44 | 2,592.61 | |
Other Current Liabilities | 3,257.72 | 1,205.88 | 4,425.04 | 4,829.77 | 2,895.29 | |
Short Term Provisions | 502.40 | 609.08 | 809.50 | 2,562.55 | 1,203.67 | |
Total Current Liabilities | 18,148.53 | 4,445.14 | 8,366.06 | 10,105.83 | 8,343.55 | |
Total Capital And Liabilities | 43,273.45 | 41,064.79 | 40,987.49 | 40,765.48 | 38,998.83 | |
ASSETS | ||||||
NON-CURRENT ASSETS | ||||||
Tangible Assets | 4,345.05 | 4,539.14 | 4,733.25 | 4,969.57 | 4,873.98 | |
Intangible Assets | 2,643.47 | 3,197.60 | 3,978.42 | 4,743.21 | 370.38 | |
Capital Work-In-Progress | 563.39 | 388.24 | 328.87 | 358.94 | 442.85 | |
Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Fixed Assets | 7,927.75 | 8,502.85 | 9,564.58 | 10,541.42 | 6,007.15 | |
Non-Current Investments | 12,410.11 | 12,429.97 | 12,416.14 | 15,355.83 | 16,967.68 | |
Deferred Tax Assets [Net] | 1,167.64 | 994.52 | 1,032.39 | 324.04 | 1,337.45 | |
Long Term Loans And Advances | 2,663.36 | 3,386.90 | 632.70 | 3,656.63 | 71.39 | |
Other Non-Current Assets | 352.20 | 796.14 | 876.53 | 1,183.81 | 2,548.82 | |
Total Non-Current Assets | 24,521.06 | 26,110.38 | 24,522.34 | 31,061.73 | 26,932.49 | |
CURRENT ASSETS | ||||||
Current Investments | 0.00 | 0.00 | 200.26 | 193.04 | 31.00 | |
Inventories | 3,787.49 | 3,423.62 | 3,989.19 | 3,403.74 | 3,165.72 | |
Trade Receivables | 11,701.43 | 8,834.16 | 7,125.02 | 4,245.16 | 6,370.62 | |
Cash And Cash Equivalents | 910.50 | 338.39 | 421.28 | 534.96 | 232.26 | |
Short Term Loans And Advances | 868.79 | 655.51 | 3,347.03 | 9.10 | 738.57 | |
OtherCurrentAssets | 1,484.18 | 1,702.73 | 1,382.37 | 1,317.75 | 1,528.17 | |
Total Current Assets | 18,752.39 | 14,954.41 | 16,465.15 | 9,703.75 | 12,066.34 | |
Total Assets | 43,273.45 | 41,064.79 | 40,987.49 | 40,765.48 | 38,998.83 | |
OTHER ADDITIONAL INFORMATION | ||||||
CONTINGENT LIABILITIES, COMMITMENTS | ||||||
Contingent Liabilities | 3,179.72 | 2,013.74 | 4,309.60 | 3,811.82 | 3,564.25 | |
CIF VALUE OF IMPORTS | ||||||
Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
EXPENDITURE IN FOREIGN EXCHANGE | ||||||
Expenditure In Foreign Currency | 7,438.61 | 6,293.15 | 7,151.14 | 7,187.43 | 3,033.37 | |
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
EARNINGS IN FOREIGN EXCHANGE | ||||||
FOB Value Of Goods | 16,840.68 | 14,268.33 | 15,405.26 | 10,633.05 | 8,449.28 | |
Other Earnings | -- | -- | -- | -- | -- | |
BONUS DETAILS | ||||||
Bonus Equity Share Capital | 183.81 | 183.81 | 183.81 | 183.81 | 183.81 | |
NON-CURRENT INVESTMENTS | ||||||
Non-Current Investments Quoted Market Value | 6.93 | 6.33 | -- | -- | 9.02 | |
Non-Current Investments Unquoted Book Value | 94.00 | 94.00 | -- | -- | 0.55 | |
CURRENT INVESTMENTS | ||||||
Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
Current Investments Unquoted Book Value | -- | -- | 200.26 | 193.04 | 31.00 |
10.09.2025
07.08.2025
04.08.2025
Buy Sun Pharmaceutical Industries; target of Rs 1875: Prabhudas Lilladher
01.08.2025
Sun Pharma Consolidated June 2025 Net Sales at Rs 13,851.40 crore, up 9.47% Y-o-Y
01.08.2025
Sun Pharma Consolidated June 2025 Net Sales at Rs 13,851.40 crore, up 9.47% Y-o-Y
31.07.2025
Sun Pharma Standalone June 2025 Net Sales at Rs 5,601.96 crore, up 24.54% Y-o-Y
22.05.2025
Sun Pharma Q4 net profit declines 19% to Rs 2,154 crore, firm declares Rs 5.50 dividend
01.02.2025
Sun Pharma Consolidated December 2024 Net Sales at Rs 13,675.46 crore, up 10.46% Y-o-Y